loading page

CRISPR system-mediated gene therapy: how flexible it used in genetic diseases
  • +3
  • zhixi liu,
  • zhi liao,
  • yan chen,
  • tingwenli huang,
  • lepei zhou,
  • hongtao xiao
zhixi liu
Sichuan Cancer Hospital and Research Institute
Author Profile
zhi liao
Sichuan Provincial People’s Hospital
Author Profile
yan chen
Sichuan Cancer Hospital and Research Institute
Author Profile
tingwenli huang
Sichuan Cancer Hospital and Research Institute
Author Profile
lepei zhou
Sichuan Cancer Hospital and Research Institute
Author Profile
hongtao xiao
Sichuan Cancer Hospital and Research Institute
Author Profile

Abstract

Abstract:In the 1960 of the 20th century, scientists firstly advanced the concept of using gene therapy to cure the human genetic disease, which aimed to carry out precisely site-specific modification on the genome for obtain long-term therapeutic effect in patients. In the next 50 years, scientists have developed many new gene editing technologies including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR), etc. These new technologies have brought milestone breakthroughs in gene therapy era. In this review, we focus on how flexible the CRISPR system used in human genetic disease-focused research, gene therapy strategies, clinical trials and discuss some of the major challenges and significant benefit for its future use in patients.